Biotech Firm GeoVax Labs Seeking FDA Approval To Launch Phase II Trials Of HIV Vaccine Candidate

 10.07.2008 16:11   medicalnewstoday.com

The Atlanta-based biotechnology firm GeoVax Labs on Tuesday announced that it is seeking FDA approval to launch Phase II clinical trials of its experimental HIV vaccine this fall, the Atlanta Journal-Constitution reports (Hendrick, Atlanta Journal-Constitution, 7/9).

World HIV/AIDS